Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
7/2021 ceased to operate
Amnis Therapeutics
Amnis Therapeutics Overview
Amnis Therapeutics is a biomedical engineering company specializing in developing, manufacturing, and marketing lifesaving endovascular technologies for emergency situations. Its mission is to provide the medical community with innovative, high-performance devices that offer a reliable, proven solution for numerous endovascular indications.
The companys AneugraftDx is a pericardium covered coronary stent for emergency vessel reconstruction in cases of acute rupture or dissection of a coronary artery, coronary aneurysm, or saphenous vein graft reperfusion.
The AneugraftNx is a neurovascular pericardium covered stent designed specifically for intracranial indications such as aneurysms, ruptures, and cavernous carotid fistulas (CCFs). The innovative, biologically covered stents provide immediate blood vessel reconstruction in a one-step procedure.
In addition to its covered stent technology, Amnis Therapeutics is expanding its product development to include other unique solutions for emergency intra-arterial interventions. The most recent of these products is the Golden Retriever, a mechanical neurothrombectomy device for the emergency treatment of acute ischemic stroke.
Amnis Therapeutics Climate Tech relevance
undefined
Companies you might be interested in
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Jan 3, 2017
www.prnewswire.com
Amnis Therapeutics Starts its First Clinical Trial with its Neuro Thrombectomy Device
#Customers
Apr 12, 2016
www.prnewswire.com
Amnis Presents Successful Thrombectomy Results, Superior to a Leading Competitor's